CVE-2023-38956 — HIGH (7.5)

Vulnerability Description

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

CVSS Score

7.5

HIGH

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

NONE

Availability

NONE

Affected Products

Vendor	Product	Versions
Zkteco	Bioaccess Ivs	3.3.1

Related Weaknesses (CWE)

CWE-22

References

http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956Third Party Advisory
http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956Third Party Advisory

FAQ

What is CVE-2023-38956?

CVE-2023-38956 is a vulnerability with a CVSS score of 7.5 (HIGH). A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

How severe is CVE-2023-38956?

CVE-2023-38956 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-38956?

Check the references section above for vendor advisories and patch information. Affected products include: Zkteco Bioaccess Ivs.